Stock 8085 HONG KONG LIFE SCIENCES AND TECHNOLOGIES GROUP LIMITED
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Hong Kong Life Sciences and Technologies Group Limited

Equities

8085

KYG4642K1040

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Hong Kong Life Sciences and Technologies Group Limited Auditor Raises 'Going Concern' Doubt
CI
Hong Kong Life Sciences and Technologies Group Limited Reports Earnings Results for the Full Year Ended March 31, 2022
CI
Hong Kong Life Sciences and Technologies Group Limited Reports Earnings Results for the First Quarter Ended June 30, 2020
CI
Hong Kong Life Sciences and Technologies Group Limited Provides Earnings Guidance for the Three Months Ended 30 June 2020
CI
Hong Kong Life Sciences and Technologies Group Limited Provides Earnings Guidance for the Full Year Ended March 31, 2020
CI
Hong Kong Life Sciences and Technologies Group Limited Announces Unaudited Consolidated Earnings Results for the Third Quarter Ended December 31, 2019
CI
Hong Kong Life Sciences and Technologies Group Limited Reports Earnings Results for the Second Quarter Ended September 30, 2019
CI
Hong Kong Life Sciences and Technologies Group Limited Reports Earnings Results for the First Quarter Ended June 30, 2019
CI
Hong Kong Life Sciences and Technologies Group Limited Provides Earnings Guidance for the Three Months Ended June 30, 2019
CI
Hong Kong Life Sciences and Technologies Group Limited Announces Consolidated Earnings Results for the Year Ended March 31, 2019
CI
Hong Kong Life Sciences and Technologies Group Limited Announces Earnings Guidance for the Year Ended 31 March 2019
CI
ZMAY Holdings Limited Accepts Fitting-Out Contract of the Contractor in Respect of the Fitting-Out Works to Be Carried Out At New Office and Customer Service Centre At the Contract Price
CI
Hong Kong Life Sciences and Technologies Group Limited Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended December 31, 2018
CI
Hong Kong Life Sciences and Technologies Group Limited Appoints Lau Ngai Cheung as Executive Director
CI
Hong Kong Life Sciences and Technologies Group Limited Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended September 30, 2018
CI
Hong Kong Life Sciences and Technologies Group Limited Announces Management Changes
CI
Hong Kong Life Sciences and Technologies Group Limited Announces Unaudited Consolidated Earnings Results for First Quarter Ended June 30, 2018
CI
Hong Kong Life Sciences and Technologies Group Limited Provides Earnings Guidance for the Three Months Ended 30 June 2018
CI
Hong Kong Life Sciences and Technologies Group Limited Announces Audited Consolidated Earnings Results for the Year Ended March 31, 2018
CI
Hong Kong Life Sciences and Technologies Group Limited Announces Unaudited Consolidated Financial Results for the Quarter and Nine Months Ended December 31, 2017
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 8085 Stock
  4. News Hong Kong Life Sciences and Technologies Group Limited